FindTrial
Sign In

Optimal Dosage of Methylprednisolone in the Treatment of Geriatric Sudden Hearing Loss: A Propensity Score-matched Analysis

Optimal Dosage of Methylprednisolone in the Treatment of Geriatric Sudden Hearing Loss: A Propensity Score-matched Analysis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0001066
Enrollment
109
Registered
2014-04-15
Start date
2014-03-17
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Eulji University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who complained of unilateral sudden hearing loss and visited eulji university hospital between May 2006 and December 2013

Exclusion criteria

Exclusion criteria: 1) concomitant meningitis, myelitis, vasculopathy or neuropsychiatric disease; 2) patients who could not be observed for at least three months; 3) previous histories of sudden hearing loss and/or the possibility of Meniere’s disease; and 4) uncontrolled hypertension or uncontrolled diabetes mellitus.

Design outcomes

Primary

MeasureTime frame
Final hearing—

Secondary

MeasureTime frame
adverse events—

Countries

Korea, Republic of

Contacts

Public ContactHO YUN LEE

Eulji University Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026